Valeant Pharmaceuticals International Inc. (NYSE: VRX) defended itself against allegations of questionable business practices but the stock price continued to fall by plunging $6.12 to close at $110.04.
Valeant defends against allegations
October 26, 2015 at 18:24 PM EDT